Venous Leg Ulcers: Advanced Therapies and New Technologies

The prevalence of venous leg ulcers (VLUs) differs between 1.5% and 3% in the general population. The challenge in treating VLUs is common recurrence. Moreover, VLUs can be resistant to healing, despite appropriate treatment. In these cases, advanced wound therapies should be considered. The number...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hubert Aleksandrowicz, Agnieszka Owczarczyk-Saczonek, Waldemar Placek
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	venous leg ulcers advanced therapies new technologies wound treatment experimental dermatology Biology (General) QH301-705.5
Acceso en línea:	https://doaj.org/article/586f1e661e824377b61b864097d9e41d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:586f1e661e824377b61b864097d9e41d
record_format	dspace
spelling	oai:doaj.org-article:586f1e661e824377b61b864097d9e41d2021-11-25T16:49:07ZVenous Leg Ulcers: Advanced Therapies and New Technologies10.3390/biomedicines91115692227-9059https://doaj.org/article/586f1e661e824377b61b864097d9e41d2021-10-01T00:00:00Zhttps://www.mdpi.com/2227-9059/9/11/1569https://doaj.org/toc/2227-9059The prevalence of venous leg ulcers (VLUs) differs between 1.5% and 3% in the general population. The challenge in treating VLUs is common recurrence. Moreover, VLUs can be resistant to healing, despite appropriate treatment. In these cases, advanced wound therapies should be considered. The number of new technologies, applied in VLUs treatment, has increased in the last years. These therapies include biophysical interventions such as ultrasound therapy, electrical stimulations, electromagnetic therapy, or phototherapy. Furthermore, stem cell therapies, biologic skin equivalents, platelet-rich plasma therapy, oxygen therapies, anti-TNF therapy, or negative pressure wound therapy are advanced venous ulcer therapeutic methods that may support the standard of care. Medical devices, such as a muscle pump activator, or intermittent pneumatic compression device, may be especially useful for specific subgroups of patients suffering from VLUs. Some of the above-mentioned technologies require broader evidence of clinical efficacy and are still considered experimental therapies in dermatology.Hubert AleksandrowiczAgnieszka Owczarczyk-SaczonekWaldemar PlacekMDPI AGarticlevenous leg ulcersadvanced therapiesnew technologieswound treatmentexperimental dermatologyBiology (General)QH301-705.5ENBiomedicines, Vol 9, Iss 1569, p 1569 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	venous leg ulcers advanced therapies new technologies wound treatment experimental dermatology Biology (General) QH301-705.5
spellingShingle	venous leg ulcers advanced therapies new technologies wound treatment experimental dermatology Biology (General) QH301-705.5 Hubert Aleksandrowicz Agnieszka Owczarczyk-Saczonek Waldemar Placek Venous Leg Ulcers: Advanced Therapies and New Technologies
description	The prevalence of venous leg ulcers (VLUs) differs between 1.5% and 3% in the general population. The challenge in treating VLUs is common recurrence. Moreover, VLUs can be resistant to healing, despite appropriate treatment. In these cases, advanced wound therapies should be considered. The number of new technologies, applied in VLUs treatment, has increased in the last years. These therapies include biophysical interventions such as ultrasound therapy, electrical stimulations, electromagnetic therapy, or phototherapy. Furthermore, stem cell therapies, biologic skin equivalents, platelet-rich plasma therapy, oxygen therapies, anti-TNF therapy, or negative pressure wound therapy are advanced venous ulcer therapeutic methods that may support the standard of care. Medical devices, such as a muscle pump activator, or intermittent pneumatic compression device, may be especially useful for specific subgroups of patients suffering from VLUs. Some of the above-mentioned technologies require broader evidence of clinical efficacy and are still considered experimental therapies in dermatology.
format	article
author	Hubert Aleksandrowicz Agnieszka Owczarczyk-Saczonek Waldemar Placek
author_facet	Hubert Aleksandrowicz Agnieszka Owczarczyk-Saczonek Waldemar Placek
author_sort	Hubert Aleksandrowicz
title	Venous Leg Ulcers: Advanced Therapies and New Technologies
title_short	Venous Leg Ulcers: Advanced Therapies and New Technologies
title_full	Venous Leg Ulcers: Advanced Therapies and New Technologies
title_fullStr	Venous Leg Ulcers: Advanced Therapies and New Technologies
title_full_unstemmed	Venous Leg Ulcers: Advanced Therapies and New Technologies
title_sort	venous leg ulcers: advanced therapies and new technologies
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/586f1e661e824377b61b864097d9e41d
work_keys_str_mv	AT hubertaleksandrowicz venouslegulcersadvancedtherapiesandnewtechnologies AT agnieszkaowczarczyksaczonek venouslegulcersadvancedtherapiesandnewtechnologies AT waldemarplacek venouslegulcersadvancedtherapiesandnewtechnologies
_version_	1718412956113305600

Venous Leg Ulcers: Advanced Therapies and New Technologies

Ejemplares similares